XML 24 R5.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF PARTNERS’ DEFICIT AND STOCKHOLDERS’ DEFICIENCY - USD ($)
Total
Limited Partners
General Partners
Redeemable Preferred Series A
Common A
Accumulated Deficit
Additional Paid-in Capital
Stock Subscriptions
[2]
Beginning balance at Dec. 31, 2019 $ (2,780,961) $ (833,875) $ (1,947,086)          
Increase (Decrease) in Partners' Capital [Roll Forward]                
Net losses (323,760) (97,128) (226,632)          
Distributions (591,119)   (591,119)          
Ending balance at Sep. 30, 2020 (3,695,840) (931,003) (2,764,837)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net losses (323,760) (97,128) (226,632)          
Beginning balance at Jun. 30, 2020 (2,810,446) (726,291) (2,084,155)          
Increase (Decrease) in Partners' Capital [Roll Forward]                
Net losses (682,374) (204,712) (477,662)          
Distributions (203,020)   (203,020)          
Ending balance at Sep. 30, 2020 (3,695,840) (931,003) (2,764,837)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net losses (682,374) (204,712) (477,662)          
Beginning balance at Dec. 31, 2020 (4,047,107) (1,336,784) (2,710,323)          
Increase (Decrease) in Partners' Capital [Roll Forward]                
Net losses (238,948) (71,687) (167,261)          
Ending balance at Mar. 31, 2021 (4,286,055) (1,408,471) (2,877,584)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net losses (238,948) (71,687) (167,261)          
Beginning balance at Dec. 31, 2020 (4,047,107) (1,336,784) (2,710,323)          
Increase (Decrease) in Partners' Capital [Roll Forward]                
Net losses (3,031,054)              
Ending balance at Sep. 30, 2021   0 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net losses (3,031,054)              
Ending balance (in shares) at Sep. 30, 2021       576,000 140,674      
Ending balance at Sep. 30, 2021 (254,175,875)     $ 58 [1] $ 14 $ (263,811,490) $ 9,635,543 $ 0
Beginning balance at Mar. 31, 2021 (4,286,055) (1,408,471) (2,877,584)          
Increase (Decrease) in Partners' Capital [Roll Forward]                
Net losses (2,959,369)         (2,959,369)    
Contributions 2,877,584 1,408,471 2,877,584          
Ending balance at Sep. 30, 2021   0 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Aspen Scrubgrass Participant, LLC [“Olympus”] contribution 0         (1,408,471)    
Buyout of Aspen Interest– refer to Note 19 (in shares)       576,000        
Buyout of Aspen Interest– refer to Note 19 (2,000,142)     $ 58 [1]   (7,000,000) 4,999,800  
Exchange of common units for Class A common shares (in shares)         14,400      
Exchange of common units for Class A common shares 2       $ 2      
Common stock issued as part of debt financing – refer to Note 14 (in shares)         54,392      
Common stock issued as part of debt financing – refer to Note 14 598,692       $ 5   598,687  
Common stock issued as part of debt financing – refer to Note 14 (in shares)         71,882      
Common stock issued as part of debt financing – refer to Note 14 791,207       $ 7   791,200  
Warrants issued as part of debt financing – refer to Note 14 1,999,396           1,999,396  
Net losses (2,959,369)         (2,959,369)    
Maximum redemption right valuation - refer to Note 15 (252,443,650)         (252,443,650)    
Stock–based compensation – refer to Note 13 1,246,459           1,246,459  
Ending balance (in shares) at Sep. 30, 2021       576,000 140,674      
Ending balance at Sep. 30, 2021 (254,175,875)     $ 58 [1] $ 14 (263,811,490) 9,635,543 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)       576,000 140,674      
Net losses (1,951,569)         (1,951,569)    
Ending balance at Sep. 30, 2021   $ 0 $ 0          
Beginning balance at Jun. 30, 2021 (174,921,113)     $ 58 $ 14 (182,190,312) 8,659,015 (1,389,888)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued as part of debt financing – refer to Note 14 598,686             598,686
Common stock issued as part of debt financing – refer to Note 14 791,202             791,202
Net losses (1,951,569)         (1,951,569)    
Maximum redemption right valuation - refer to Note 15 (79,669,608)         (79,669,608)    
Stock–based compensation – refer to Note 13 976,527           976,527  
Ending balance (in shares) at Sep. 30, 2021       576,000 140,674      
Ending balance at Sep. 30, 2021 $ (254,175,875)     $ 58 [1] $ 14 $ (263,811,490) $ 9,635,543 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)       576,000 140,674      
[1] Refer to Note 19- Aspen Interest (“Olympus”) Buyout for further information
[2] Refer to Note 14- Stock Issued Under Master Financing Agreements and Warrants for further information